| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b6d851b04ea5f7241b6c07c462ad343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1b2290316913a58a90bc6d3584603a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62f4f46129e80ef907c188099adbb95a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9092c90fd86471f706dcc2ab78cb6295 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 |
| filingDate |
2020-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55f4db6ffa9e9f29616a45f4f65ff187
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eb0a121f715e84600e523f2fa6ce9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a807197838d8728809050df5636b1380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_777e769bb6a3aa32a088a39e64cc4a23 |
| publicationDate |
2021-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021106543-A1 |
| titleOfInvention |
Curcuminoid composition for therapeutic management of metabolic syndrome |
| abstract |
The present invention discloses a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids and its therapeutic application. More specifically, the present invention discloses the use of a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids in the therapeutic management of metabolic syndrome in mammals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022133022-A1 |
| priorityDate |
2019-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |